Skip to main content

Advertisement

SpringerLink
Log in

Therapy for thymic epithelial tumors

  • Current Topics Review Article
  • Published:
General Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Thymoma is the most common tumor of the anterior mediastinum. This tumor is associated with unique paraneoplastic syndromes. The rarity of this tumor has somewhat obscured the optimal treatment for this disease. The World Health Organization classification system, which published in 1999, appears to be an advance in our understanding of thymoma. The Masaoka classification is now the most widely accepted and is an excellent predictor of the prognosis of thymoma. Now the International Thymic Malignancy Interest Group is currently engaged in the development of a validated formal TNM classification system for thymic malignancies. The optimal treatment of thymoma is performed according to its clinical stage. Surgery remains the mainstay of treatment for thymic epithelial tumors. Minimally invasive surgery including thoracoscopic surgery and robotic surgery for stage I and II thymomas is increasing now. The value of postoperative radiotherapy in completely resected stage II or III tumors is questionable. As thymomas have a moderate response rate to chemotherapy or radiotherapy, multimodality therapy involving surgery, chemotherapy and radiotherapy appears to increase the rate of complete resection and survival in the advanced (stage III and IV) thymomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kuwano H, Amano J, Yokomise H. Thoracic and cardiovascular surgery in Japan during 2010 Annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg. 2012;60:680–708.

    Article  PubMed  Google Scholar 

  2. Shimosato Y. Controversies surrounding the subclassification of thymoma. Cancer. 1994;74:542–4.

    Article  CAS  PubMed  Google Scholar 

  3. Rosai J. Histological typing of tumours of the thymus. In: International histological classification of tumours, 2nd ed. New York: Springer; 1999.

  4. Shimosato Y, Mukai K, Matsuno Y. Tumors of the mediastinum. In: Silverberg SG, editor. AFIP atlas of tumor pathology, 4th series, fascicle 11. Washington, DC: Armed Forces Institute of Pathology; 2010.

    Google Scholar 

  5. Shields TW. Thymic tumors. In: Shields TW, editor. Mediastinal surgery. Philadelphia: Lea & Febiger; 1991. p. 153–73.

    Google Scholar 

  6. Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg. 2003;76:878–84.

    Article  PubMed  Google Scholar 

  7. Hejna M, Haberl I, Raderer M. Nonsurgical management of malignant thymoma. Cancer. 1999;85:1871–84.

    Article  CAS  PubMed  Google Scholar 

  8. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. Pathology and genetics of tumours of the lung, pleura, thymus and heart. In: WHO classification of tumours, 2nd ed. Lyon: IARC Press; 2004. pp. 145–197.

  9. Detterbeck F. Clinical value of the WHO classification system of thymoma. Ann Thorac Surg. 2006;81:2328–34.

    Article  PubMed  Google Scholar 

  10. Bergh NP, Gatzinsky P, Larsson S, Lundin P, Ridell B. Tumors of the thymus and thymic region: I. Clinicopathological studies on thymomas. Ann Thorac Surg. 1978;25:91–8.

    Article  CAS  PubMed  Google Scholar 

  11. Wilkins EW Jr, Castleman B. Thymoma: a continuing survey at the Massachusetts General Hospital. Ann Thorac Surg. 1979;28:252–6.

    Article  PubMed  Google Scholar 

  12. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981;48:2485–92.

    Article  CAS  PubMed  Google Scholar 

  13. Detterbeck FC, Parsons AM. Thymic tumors. Ann Thorac Surg. 2004;77:1860–9.

    Article  PubMed  Google Scholar 

  14. Kondo K. Optimal therapy for thymoma. J Med Invest. 2008;55:17–28.

    Article  PubMed  Google Scholar 

  15. Detterbeck FC, Nicholson AG, Kondo K, Van Schil P, Moran C. The Masaoka-Koga stage classification for thymic malignancies clarification and definition of terms. J Thorac Oncol. 2011;6:S1710–6.

    Article  PubMed  Google Scholar 

  16. Thomas CR, Wright CD, Loehrer PJ. Thymoma: state of the art. J Clin Oncol. 1999;17:2280–9.

    CAS  PubMed  Google Scholar 

  17. Toker A, Sonett J, Zielinski M, Rea F, Tomulescu V, Detterbeck FC. Standard terms, definitions, and policies for minimally invasive resection of thymoma. J Thorac Oncol. 2011;6:S1739–42.

    Article  PubMed  Google Scholar 

  18. Marulli G, Rea F, Melfi F, Schmid TA, Ismail M, Fanucchi O, et al. Robot-aided thoracoscopic thymectomy for early-stage thymoma: a multicenter European study. J Thorac Cardiovasc Surg. 2012;144:1125–32.

    Article  PubMed  Google Scholar 

  19. Monden Y, Nakahara K, Iioka S, Nanjo S, Ohno K, Fujii Y, et al. Recurrence of thymoma: clinicopathological features, therapy, and prognosis. Ann Thorac Surg. 1985;39:165–9.

    Article  CAS  PubMed  Google Scholar 

  20. Curran WJ Jr, Kornstein MJ, Brooks JJ, Turrisi AT 3rd. Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol. 1988;6:1722–7.

    PubMed  Google Scholar 

  21. Quintanilla-Martinez L, Wilkins EW Jr, Choi N, Efird J, Hug E, Harris NL. Thymoma histologic subclassification is an independent prognostic factor. Cancer. 1994;74:606–17.

    Article  CAS  PubMed  Google Scholar 

  22. Blumberg D, Port JL, Weksler B, Delgado R, Rosai J, Bains MS, et al. Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg. 1995;60:908–14.

    Article  CAS  PubMed  Google Scholar 

  23. Regnard J-F, Magdeleinat P, Dromer C, Dulmet E, de Montpreville V, Levi JF, et al. Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg. 1996;112:376–84.

    Article  CAS  PubMed  Google Scholar 

  24. Haniuda M, Morimoto M, Nishimura H, Kobayashi O, Yamanda T, Iida F. Adjuvant radiotherapy after complete resection of thymoma. Ann Thorac Surg. 1992;54:311–5.

    Article  CAS  PubMed  Google Scholar 

  25. Ruffini E, Mancuso M, Oliaro A, Casadio C, Cavallo A, Cianci R, et al. Recurrence of thymoma: analysis of clinicopathologic features, treatment and outcome. J Thorac Cardiovasc Surg. 1997;113:55–63.

    Article  CAS  PubMed  Google Scholar 

  26. Mangi AA, Wright CD, Allan JS, Wain JC, Donahue DM, Grillo HC, et al. Adjuvant radiation therapy for stage II thymoma. Ann Thorac Surg. 2002;74:1033–7.

    Article  PubMed  Google Scholar 

  27. Mangi AA, Wain JC, Donahue DM, Grillo HC, Mathisen DJ, Wright CD. Adjuvant radiation of stage III thymoma: is it necessary? Ann Thorac Surg. 2005;79:1834–9.

    Article  PubMed  Google Scholar 

  28. Singhal S, Shrager JB, Rosenthal DI, LiVolsi VA, Kaiser LR. Comparison of stages I—II thymoma treated by complete resection with or without adjuvant radiation. Ann Thorac Surg. 2003;76:1635–42.

    Article  PubMed  Google Scholar 

  29. Rena O, Papalia E, Oliaro A, Ruffini E, Filosso P, Novero D, et al. Does adjuvant radiation therapy improve disease-free survival in completely resected Masaoka stage II thymoma? Eur J Cardiothorac Surg. 2007;31:109–13.

    Article  PubMed  Google Scholar 

  30. Korst RJ, Kansler AL, Christos PJ, Mandal S. Adjuvant radiotherapy for thymic epithelial tumors: a systematic review and meta-analysis. Ann Thorac Surg. 2009;87:1641–7.

    Article  PubMed  Google Scholar 

  31. Macchiarini P, Chella A, Ducci F, Rossi B, Testi C, Bevilacqua G, et al. Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma. Cancer. 1991;68:706–13.

    Article  CAS  PubMed  Google Scholar 

  32. Berruti A, Borasio P, Roncari A, Gorzegno G, Mossetti C, Dogliotti L. Neoadjuvant chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide (ADOC) in invasive thymomas: results in six patients. Ann Oncol. 1993;4:429–31.

    CAS  PubMed  Google Scholar 

  33. Rea F, Sartori F, Loy M, Calabrò F, Fornasiero A, Daniele O, et al. Chemotherapy and operation for invasive thymoma. J Thorac Cardiovasc Surg. 1993;106:543–9.

    CAS  PubMed  Google Scholar 

  34. Shin DM, Walsh GL, Komaki R, Putnam JB, Nesbitt J, Ro JY, et al. A multidisciplinary approach to therapy for unresectable malignant thymoma. Ann Intern Med. 1998;129:100–4.

    Article  CAS  PubMed  Google Scholar 

  35. Venuta F, Rendina EA, Pescarmona EO, De Giacomo T, Vegna ML, Fazi P, et al. Multimodality treatment of thymoma: a prospective study. Ann Thorac Surg. 1997;64:1585–92.

    Article  CAS  PubMed  Google Scholar 

  36. Bretti S, Berruti A, Loddo C, Sperone P, Casadio C, Tessa M, et al. Multimodal management of stages III-IVa malignant thymoma. Lung Cancer. 2004;44:69–77.

    Article  CAS  PubMed  Google Scholar 

  37. Kim ES, Putnam JB, Komaki R, Walsh GL, Ro JY, Shin HJ, et al. A phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer. 2004;44:369–79.

    Article  PubMed  Google Scholar 

  38. Lucchi M, Melfi F, Dini P, Basolo F, Viti A, Givigliano F, et al. Neoadjuvant chemotherapy for stage III and IVa thymomas: a single-institution experience with a long follow-up. J Thorac Oncol. 2006;1:308–13.

    Article  PubMed  Google Scholar 

  39. Yokoi K, Matsuguma H, Nakahara R, Kondo T, Kamiyama Y, Mori K, et al. Multidisciplinary treatment for advanced invasive thymoma with cisplatin, doxorubicin, and methylpredonisone. J Thorac Oncol. 2007;2:73–8.

    Article  PubMed  Google Scholar 

  40. Kunitoh H, Tamura T, Shibata T, Takeda K, Katakami N, Nakagawa K, et al. A phase II trial of dose-dense chemotherapy, followed by surgical resection and/or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606). Br J Cancer. 2010;103:6–11.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  41. Maggi G, Casadio C, Cavallo A, Cianci R, Molinatti M, Ruffini E. Thymoma: results of 241 operated cases. Ann Thorac Surg. 1991;51:152–6.

    Article  CAS  PubMed  Google Scholar 

  42. Nakahara K, Ohno K, Hashimoto J, Maeda H, Miyoshi S, Sakurai M, et al. Thymoma. Results with complete resection and adjuvant postoperative irradiation in 141 consecutive patients. J Thorac Cardiovasc Surg. 1988;95:1041–7.

    CAS  PubMed  Google Scholar 

  43. Mornex F, Resbeut M, Richaud P, Jung GM, Mirabel X, Marchal C, et al. Radiotherapy and chemotherapy for invasive thymomas: a multicentric retrospective review of 90 cases. The FNCLCC trialists. Federation Nationale des Centres de Lutte Contre le Cancer. Int J Radiat Oncol Biol Phys. 1995;32:651–9.

    Article  CAS  PubMed  Google Scholar 

  44. Wang LS, Huang MH, Lin TS, Huang B-S, Chien KY. Malignant thymoma. Cancer. 1992;70:443–50.

    Article  CAS  PubMed  Google Scholar 

  45. Jackson MA, Ball DL. Post-operative radiotherapy in invasive thymoma. Radiother Oncol. 1991;21:77–82.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

All the authors have declared no competing interest.

Author information

Authors and Affiliations

  1. Department of Oncological Medical Services, Institute of Health Biosciences, The University of Tokushima Graduate School, 18-15 Kuramoto-cho 3, Tokushima, 770-8509, Japan

    Kazuya Kondo

Authors
  1. Kazuya Kondo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kazuya Kondo.

Additional information

This review was submitted at the invitation of the editorial committee.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kondo, K. Therapy for thymic epithelial tumors. Gen Thorac Cardiovasc Surg 62, 468–474 (2014). https://doi.org/10.1007/s11748-014-0420-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11748-014-0420-z

Keywords

Search

Navigation